Joint SITC-ESMO Immunotherapy Primer Session

When:  Dec 8, 2021 from 08:30 to 12:00 (CET)
The Joint SITC - European Society for Medical Oncology (ESMO) Immuno-Oncology Primer will take place as a hybrid event in Geneva, Switzerland on December 8, 2021. This primer program will occur prior to and in conjunction with the ESMO-IO Congress taking place on the following days.

In recent years, SITC and ESMO have collaboratively worked together to provide basic immunotherapy education prior to numerous ESMO international programs, including ESMO-IO and ESMO-Asia. Attendees have indicated that such education has been incredibly valuable for their own research and clinical responsibilities.

Bernard Fox, PhD – Providence Cancer Institute
Tanja de Gruijl, PhD – Amsterdam University Medical Centers

Cristina Bergamaschi, PhD – National Cancer Institute
Stephane Champiat, MD, PhD – Institut Gustave Roussy

Marco Donia, MD, PhD – Herlev and Gentofte Hospital, Denmark
Yvette Van Kooyk, PhD – AmsterdamUMC

  • 8:30-8:45 a.m. CET: Welcome 
  • 8:45-9:10 a.m. CET: Session 1Bernard Fox, PhD
  • 9:10-9:35 a.m. CET: Session 2Yvette Van Kooyk, PhD 
  • 9:35-9:45 a.m. CET: Break
  • 9:45-10:10 a.m. CET: Session 3 – Tanja de Gruijl, PhD 
    • 10:10-10:35 a.m. CET: Session 4 Cristina Bergamaschi, PhD 
    • 10:35-10:45 a.m. CET: Break 
    • 10:45-11:10 a.m. CET: Session 5 Stephane Champiat, MD, PhD 
    • 11:10-11:35 a.m. CET: Session 6 Marco Donia, MD, PhD 
    • 11:35-11:55 a.m. CET: Panel Session All Faculty 
    • 11:55-12:00 p.m. CET: Conclusion 


      Palexpo Congress Centre
      30 Route François-Peyrot
      1218 Le Grand-Saconnex
      Online Instructions:
      Login: To access ESMO Immuno-Oncology Congress virtually you must register using the link provided.